Literature DB >> 11750832

Suspension cultivation of Mycobacterium ulcerans for the production of mycolactones.

L D Cadapan1, R L Arslanian, J R Carney, S M Zavala, P L Small, P Licari.   

Abstract

Mycolactones are polyketide toxins produced by Mycobacterium ulcerans, the causative agent of the tropical skin disease known as Buruli ulcer. Development of novel therapeutic agents from mycolactones has been hindered by the difficulty of producing sufficient amounts of material. Here, we describe the successful adaptation of M. ulcerans to suspension cultivation and the development of a fed-batch fermentation process that was scaled up to 150 l. In addition to producing mycolactones A and B, a number of new mycolactone-related compounds were also observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750832     DOI: 10.1111/j.1574-6968.2001.tb10977.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

1.  A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.

Authors:  Armand Mve-Obiang; Richard E Lee; Edward S Umstot; Kristin A Trott; Timothy C Grammer; John M Parker; Brian S Ranger; Robert Grainger; Engu A Mahrous; P L C Small
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F.

Authors:  Brian S Ranger; Engy A Mahrous; Lydia Mosi; Sarojini Adusumilli; Richard E Lee; Angelo Colorni; Martha Rhodes; P L C Small
Journal:  Infect Immun       Date:  2006-08-21       Impact factor: 3.441

Review 3.  The chemistry and biology of mycolactones.

Authors:  Matthias Gehringer; Karl-Heinz Altmann
Journal:  Beilstein J Org Chem       Date:  2017-08-11       Impact factor: 2.883

4.  Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.

Authors:  Armand Mve-Obiang; Richard E Lee; Françoise Portaels; P L C Small
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

5.  Structure-activity relationship studies on the macrolide exotoxin mycolactone of Mycobacterium ulcerans.

Authors:  Nicole Scherr; Philipp Gersbach; Jean-Pierre Dangy; Claudio Bomio; Jun Li; Karl-Heinz Altmann; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28

6.  Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.

Authors:  Hui Hong; Emmanuelle Coutanceau; Marion Leclerc; Laxmee Caleechurn; Peter F Leadlay; Caroline Demangel
Journal:  PLoS Negl Trop Dis       Date:  2008-10-22

7.  A novel mycolactone toxin obtained by biosynthetic engineering.

Authors:  Hui Hong; Tim Stinear; Jessica Porter; Caroline Demangel; Peter F Leadlay
Journal:  Chembiochem       Date:  2007-11-23       Impact factor: 3.164

8.  Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis.

Authors:  Laurent Marsollier; Priscille Brodin; Mary Jackson; Jana Korduláková; Petra Tafelmeyer; Etienne Carbonnelle; Jacques Aubry; Geneviève Milon; Pierre Legras; Jean-Paul Saint André; Céline Leroy; Jane Cottin; Marie Laure Joly Guillou; Gilles Reysset; Stewart T Cole
Journal:  PLoS Pathog       Date:  2007-05-04       Impact factor: 6.823

Review 9.  Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria.

Authors:  Hui Hong; Caroline Demangel; Sacha J Pidot; Peter F Leadlay; Tim Stinear
Journal:  Nat Prod Rep       Date:  2008-04-17       Impact factor: 13.423

10.  Mycobacterium ulcerans fails to infect through skin abrasions in a guinea pig infection model: implications for transmission.

Authors:  Heather R Williamson; Lydia Mosi; Robert Donnell; Maha Aqqad; Richard W Merritt; Pamela L C Small
Journal:  PLoS Negl Trop Dis       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.